A new RNAi biotech is breaking ground with $135 million and John Maraganore, Ph.D., holding the key to the city. | A new RNAi ...

City Therapeutics, based in Cambridge, is developing new medicines that use RNA interference, or RNAi, to silence genes and ...

City Therapeutics, Inc. announced its launch today with a vision to lead the future of RNA interference (RNAi)-based medicine. City Therapeuticstm aims to harness next-generation engineering of small ...

The time to re-enter the RNAi revolution is now,” said Robert Nelsen, the managing director of Arch, which led the Series A funding round for City Therapeutics.

In the late 1980s, Ambros and Ruvkun were postdoctoral researchers in the laboratory of Robert Horvitz, who received the ...

WORCESTER ― Victor R. Ambros could have worn anything to Monday morning's press conference at UMass Chan Medical School that ...

Food allergies drive consumer choice and loyalty in the Canadian dining scene. According to new research from Food Allergy Canada, 80% of people with food allergies and 44% of those without say that ...

Researchers developed novel genetic tools to trace, ablate, and manipulate p16^Ink4a+^ senescent cells, revealing their ...

The results of Haryana and Jammu and Kashmir Assembly elections will be out later today. The counting of votes for the 2024 ...

The scientist was the first author of the pioneering ‘Cell’ study on microRNA, but it is typically the last author who is recognized as the leader of the research group ...

Later on Monday, the Israel Defense Forces (IDF) said that its air force targeted more than 120 Hezbollah sites in southern ...

Peraso Inc. (NASDAQ: PSRO)'s Millimeter Wave (mmWave) technology, operating in the 24-300 GHz range, is vital for ...